Insulin degludec
Tresiba (insulin degludec) is a protein pharmaceutical. Insulin degludec was first approved as Tresiba on 2013-01-20. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.
| Trade Name | Tresiba |
|---|---|
| Common Name | Insulin degludec |
| Indication | diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus |
| Drug Class |
